BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10926081)

  • 1. Neoadjuvant and adjuvant hormone therapy for prostate cancer.
    Zlotta AR; Schulman CC
    World J Urol; 2000 Jun; 18(3):179-82. PubMed ID: 10926081
    [No Abstract]   [Full Text] [Related]  

  • 2. Neoadjuvant and adjuvant hormonal and chemotherapy for prostate cancer.
    Lam ET; Glodé LM
    Hematol Oncol Clin North Am; 2013 Dec; 27(6):1189-204, viii. PubMed ID: 24188258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neoadjuvant hormone therapy before prostatectomy for cancer localized to the prostate].
    Boccon-Gibod L
    Prog Urol; 1997 Feb; 7(1):97-8. PubMed ID: 9116748
    [No Abstract]   [Full Text] [Related]  

  • 4. [Neoadjuvant hormone therapy with total radical prostatectomy: intermediate results].
    Hermans BP; Lorge F; Wese FX; Opsomer RJ; Van Cangh PJ
    Acta Urol Belg; 1996 Mar; 64(1):27-31. PubMed ID: 8659332
    [No Abstract]   [Full Text] [Related]  

  • 5. [Adjuvant and neoadjuvant drug therapy for prostate cancer].
    Miller K; Lein M; Schostak M; Schrader M
    Urologe A; 2008 Nov; 47(11):1460-4. PubMed ID: 18813902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of neoadjuvant therapy for prostate cancer].
    Okada K; Hachiya T
    Nihon Hinyokika Gakkai Zasshi; 1997 Sep; 88(9):769-77. PubMed ID: 9364842
    [No Abstract]   [Full Text] [Related]  

  • 7. [Is maximal androgenic blockade necessary in the treatment of prostatic cancer?].
    Matveev BP; Bukharkin BV
    Urologiia; 2003; (6):6-10. PubMed ID: 14708235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is there an indication for adjuvant or neoadjuvant systemic therapy in prostate cancer?].
    Börgermann C; Miller K; vom Dorp F; Jäger T; Rübben H
    Urologe A; 2007 Oct; 46(10):1385-6, 1388. PubMed ID: 17874231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic treatment for prostate cancer.
    Horwich A
    Ann Oncol; 2006 Sep; 17 Suppl 10():x211-3. PubMed ID: 17018726
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of neoadjuvant and adjuvant therapy to prevent or delay recurrence of prostate cancer in patients undergoing surgical treatment for prostate cancer.
    Gomella LG; Zeltser I; Valicenti RK
    Urology; 2003 Dec; 62 Suppl 1():46-54. PubMed ID: 14747041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant hormone therapy before radical prostatectomy does not improve disease-specific survival.
    Steiner MS
    Curr Urol Rep; 2000 May; 1(1):7-8. PubMed ID: 12084334
    [No Abstract]   [Full Text] [Related]  

  • 12. Adjuvant and neoadjuvant hormonal therapy for prostate cancer.
    Tyrrell CJ
    Eur Urol; 1999 Dec; 36(6):549-58. PubMed ID: 10559607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Future prospects for primary hormone therapy in localized and locally advanced prostate cancer].
    Akaza H; Hirao Y; Labrie F; Soloway MS
    Hinyokika Kiyo; 2003 Dec; 49(12):771-7. PubMed ID: 14978964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoma of the prostate: neoadjuvant hormonotherapy followed by radiotherapy.
    Scalliet P
    Acta Urol Belg; 1996 May; 64(2):63-4. PubMed ID: 8701815
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of prostate cancer].
    Imre R
    Orv Hetil; 2005 Aug; 146(35):1839-42. PubMed ID: 16187544
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of adjuvant androgen deprivation therapy after radical prostatectomy on the survival of patients with pathological T3b prostate cancer.
    Siddiqui SA; Boorjian SA; Blute ML; Rangel LJ; Bergstralh EJ; Karnes RJ; Frank I
    BJU Int; 2011 Feb; 107(3):383-8. PubMed ID: 21265985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant hormonal therapy in the management of prostate cancer: a surgical and radiation therapy review.
    Soderdahl DW; Wettlaufer JN; Corn B; Gomella LG
    Tech Urol; 1996; 2(4):194-206. PubMed ID: 9085540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adjuvant or therapeutic androgen suppression in locoregional advanced prostatic carcinoma (RTOG 85-31)].
    Hinkelbein W
    Strahlenther Onkol; 1998 Jul; 174(7):385-6. PubMed ID: 9689964
    [No Abstract]   [Full Text] [Related]  

  • 19. Adjuvant hormonotherapy in patients with clinically-localized prostate cancer treated by radical prostatectomy: pathological results.
    Têtu B
    Can J Oncol; 1994 Nov; 4 Suppl 1():33-4; discussion 35-6. PubMed ID: 8853487
    [No Abstract]   [Full Text] [Related]  

  • 20. Neoadjuvant hormonal treatment before radical prostatectomy.
    Watson RB; Soloway MS
    Semin Urol Oncol; 1996 May; 14(2 Suppl 2):48-55; discussion 55-6. PubMed ID: 8725891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.